Literature DB >> 23212272

Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography.

Peter J Cawley1, Christian Hamilton-Craig, David S Owens, Eric V Krieger, Wendy E Strugnell, Lee Mitsumori, Caryn L D'Jang, Rebecca G Schwaegler, Khanh Q Nguyen, Bianca Nguyen, Jeffrey H Maki, Catherine M Otto.   

Abstract

BACKGROUND: Both transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) imaging allow quantification of chronic aortic regurgitation (AR) and mitral regurgitation (MR). We hypothesized that CMR measurement of regurgitant volume (RVol) is more reproducible than TTE. METHODS AND
RESULTS: TTE and CMR performed on the same day in 57 prospectively enrolled adults (31 with AR, 26 with MR) were measured by 2 independent physicians. TTE RVol(AR) was calculated as Doppler left ventricular outflow minus inflow stroke volume. RVol(MR) was calculated by both the proximal isovelocity surface area method and Doppler volume flow at 2 sites. CMR RVol(AR) was calculated by phase-contrast velocity mapping at the aortic sinuses and RVol(MR) as total left ventricular minus forward stroke volume. Intraobserver and interobserver variabilities were similar. For AR, the Bland-Altman mean interobserver difference in RVol was -0.7 mL (95% confidence interval [CI], -5 to 4) for CMR and -9 mL (95% CI, -53 to -36) for TTE. The Pearson correlation was higher (P=0.001) between CMR (0.99) than TTE readers (0.89). For MR, the Bland-Altman mean difference in RVol between observers was -4 mL (95% CI, -21 to 13) for CMR compared with 0.7 mL (95% CI, -30 to 32) for the proximal isovelocity surface area and -10 mL (95% CI, -76 to 56) for TTE volume flow at 2 sites. Correlation was similar for CMR (0.94) versus TTE readers (0.90 for the proximal isovelocity surface area).
CONCLUSIONS: Compared with TTE, CMR has lower intraobserver and interobserver variabilities for RVol(AR), suggesting CMR may be superior for serial measurements. Although RVol(MR) is similar by TTE and CMR, variability in measured RVol by both approaches suggests that caution is needed in clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 23212272     DOI: 10.1161/CIRCIMAGING.112.975623

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  55 in total

1.  Quantitation of mitral regurgitation after percutaneous MitraClip repair: comparison of Doppler echocardiography and cardiac magnetic resonance imaging.

Authors:  Christian Hamilton-Craig; Wendy Strugnell; Niranjan Gaikwad; Matthew Ischenko; Vicki Speranza; Jonathan Chan; Johanne Neill; David Platts; Gregory M Scalia; Darryl J Burstow; Darren L Walters
Journal:  Ann Cardiothorac Surg       Date:  2015-07

2.  Phase-Contrast Magnetic Resonance Quantification of Aortic Regurgitation in Patients With Turbulent Aortic Flow.

Authors:  Elizabeth Lee; Blair Richards; Jimmy C Lu; Maryam Ghadimi Mahani; Adam L Dorfman; Sowmya Balasubramanian; Prachi P Agarwal
Journal:  J Comput Assist Tomogr       Date:  2019 Mar/Apr       Impact factor: 1.826

3.  Mitral regurgitation quantification by cardiovascular magnetic resonance: a comparison of indirect quantification methods.

Authors:  Christian L Polte; Odd Bech-Hanssen; Åse A Johnsson; Sinsia A Gao; Kerstin M Lagerstrand
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-23       Impact factor: 2.357

4.  Aortic regurgitation assessment by cardiovascular magnetic resonance imaging and transthoracic echocardiography: intermodality disagreement impacting on prediction of post-surgical left ventricular remodeling.

Authors:  Ulf Neisius; Connie W Tsao; Thomas H Hauser; Apranta D Patel; Patrick Pierce; Eyal Ben-Assa; Reza Nezafat; Warren J Manning
Journal:  Int J Cardiovasc Imaging       Date:  2019-08-14       Impact factor: 2.357

5.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 6.  Aortic valvular imaging with cardiovascular magnetic resonance: seeking for comprehensiveness.

Authors:  Gianluca De Rubeis; Nicola Galea; Isabella Ceravolo; Gian Marco Dacquino; Iacopo Carbone; Carlo Catalano; Marco Francone
Journal:  Br J Radiol       Date:  2019-07-18       Impact factor: 3.039

7.  Real-time phase contrast magnetic resonance imaging for assessment of haemodynamics: from phantom to patients.

Authors:  Julius Traber; Lennart Wurche; Matthias A Dieringer; Wolfgang Utz; Florian von Knobelsdorff-Brenkenhoff; Andreas Greiser; Ning Jin; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2015-07-19       Impact factor: 5.315

8.  Anticipating the Vicious Circle of Postinfarction Mitral Regurgitation: Imaging Insights.

Authors:  Jacob P Dal-Bianco; Philipp E Bartko; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2016-07       Impact factor: 7.792

9.  Direct measurement of aortic regurgitation with phase-contrast magnetic resonance is inaccurate: proposal of an alternative method of quantification.

Authors:  Yoichi Iwamoto; Akio Inage; George Tomlinson; Kyong Jin Lee; Lars Grosse-Wortmann; Mike Seed; Andrea Wan; Shi-Joon Yoo
Journal:  Pediatr Radiol       Date:  2014-06-18

10.  Cardiac magnetic resonance assessment of mitral regurgitation severity appears better than echocardiographic imaging.

Authors:  Ayman K M Hassan; Magdy I Algowhary; Aya Y T Kishk; Amr Ahmed Aly Youssef; Nady A Razik
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-03       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.